↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

1,916 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 (11c)pe2i - - - - 1件:  6  💬
2 (2-chloro-5-[11c]methoxy-n-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide) - - - - 1件:  6  💬
3 (3beta, 5beta, 25r)-spirostan-3-ol - - - - 1件:  6  💬
4 (3ß, 5ß, 25r)-spirostan-3-ol - - - - 1件:  6  💬
5 (6s)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol - - - - 1件:  6  💬
6 (minus)-l-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate - - - - 1件:  6  💬
7 (r)-troloxamide quinone - - - - 1件:  6  💬
8 (s)- 2- amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol - - - - 1件:  6  💬
9 (s)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate - - - - 1件:  6  💬
10 0 mg tropicamide Tropicamide 1件: D00397 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
11 0.04 mg lu ae04621 - - - - 1件:  6  💬
12 0.08 mg lu ae04621 - - - - 1件:  6  💬
13 0.2 mg lu ae04621 - - - - 1件:  6  💬
14 0.3 mg tropicamide Tropicamide 1件: D00397 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
15 0.4 mg lu ae04621 - - - - 1件:  6  💬
16 0.6 mg lu ae04621 - - - - 1件:  6  💬
17 0.8 mg lu ae04621 - - - - 1件:  6  💬
18 0.9% sodium chloride Chloride ion 1件: D02056 💬 - - 4件:  6 , 14, 51, 53 💬
19 0.9% sodium chloride (normal saline) Chloride ion 1件: D02056 💬 - - 1件:  6  💬
20 00000 - - - - 1件:  6  💬
21 000000 - - - - 1件:  6  💬
22 009-0 - - - - 1件:  6  💬
23 009-1 - - - - 1件:  6  💬
24 009-2 - - - - 1件:  6  💬
25 009-3 - - - - 1件:  6  💬
26 009-4 - - - - 1件:  6  💬
27 009-5 - - - - 1件:  6  💬
28 009-a0 - - - - 1件:  6  💬
29 009-a1 - - - - 1件:  6  💬
30 009-a2 - - - - 1件:  6  💬
31 009-a3 - - - - 1件:  6  💬
32 1 mg qd to 15 mg qd pf-06649751 Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
33 1 mg qd to 7 mg qd pf-06649751 (if de-escalated in parent study) Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
34 1 mg tropicamide Tropicamide 1件: D00397 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
35 1. tesofensine (ns 2330) Tesofensine - - - 1件:  6  💬
36 1.0 mg lu ae04621 - - - - 1件:  6  💬
37 1.0 mg rasagiline mesylate Rasagiline 3件: D02562, D08469, D10829 💬 1件: MAOB 💬 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
38 1.2 mg lu ae04621 - - - - 1件:  6  💬
39 100 - - - - 2件:  6 , 97 💬
40 11c-methylreboxetine - - - - 2件:  6 , 17 💬
41 11c-pbr28 - - - - 2件:  6 , 13 💬
42 11c-pib - - - - 2件:  6 , 13 💬
43 11c-raclopride Raclopride - - - 1件:  6  💬
44 125 - - - - 1件:  6  💬
45 13n-ammonia Ammonia 1件: D02916 💬 - - 2件:  6 , 17 💬
46 15 mg qd de-escalated to 7 mg qd pf-06649751 in parent study remain at 7 mg qd Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
47 15 mg qd pf-06649751 Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
48 15o h2o - - - - 1件:  6  💬
49 18-fdtbz - - - - 1件:  6  💬
50 18f florbetaben - - - - 1件:  6  💬
51 18f- dtbz - - - - 1件:  6  💬
52 18f-av-133 Florbenazine F-18 - - - 1件:  6  💬
53 18f-av-45 - - - - 2件:  6 , 127 💬
54 18f-dopa - - - - 3件:  6 , 17, 75 💬
55 18f-dopa pet - - - - 1件:  6  💬
56 18f-dopamne - - - - 2件:  6 , 17 💬
57 18f-dtbz - - - - 1件:  6  💬
58 18f-dtbz av-133 - - - - 1件:  6  💬
59 18f-fdg Fludeoxyglucose (18F) - - - 12件:  5 ,  6 ,  7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬
60 1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- - - - - 1件:  6  💬
61 1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea - - - - 1件:  6  💬
62 1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- - - - - 1件:  6  💬
63 1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea - - - - 1件:  6  💬
64 2 mg perampanel Perampanel 1件: D08964 💬 4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 1件:  6  💬
65 2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide - - - - 1件:  6  💬
66 2-[[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4- piperidinyl]-5-oxo-2-pyrrolidinyl]carbonyl]amino]- n,n,6-trimethyl-4-pyridinecarboxamide,dihydrochloride - - - - 2件:  6 , 162 💬
67 200 mg bia 6-512 BIA - - - 1件:  6  💬
68 207-3120 - - - - 1件:  6  💬
69 240mg amantadine hcl er tablets Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
70 25 mg bia9 1067 - - - - 1件:  6  💬
71 25 mg ongentys - - - - 1件:  6  💬
72 25330 - - - - 1件:  6  💬
73 3 mg qd to 15 mg qd pf-06649751 Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
74 3 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study) Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
75 3 mg tropicamide Tropicamide 1件: D00397 💬 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 1件:  6  💬
76 3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate - - - - 1件:  6  💬
77 3-(3,4-dihydroxyphenyl)-l-alanine Alanine 1件: D00012 💬 - - 1件:  6  💬
78 320mg amantadine hcl er tablets Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
79 4 mg perampanel Perampanel 1件: D08964 💬 4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 1件:  6  💬
80 50 mg bia 9 1067 BIA - - - 1件:  6  💬
81 50 mg ongentys - - - - 1件:  6  💬
82 6abeta - apomorphine-10,11-diol hydrochloride hemihydrate Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
83 6aß - apomorphine-10,11-diol hydrochloride hemihydrate Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
84 7 mg qd to 15 mg qd pf-06649751 Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
85 7 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study) Tavapadon 1件: D11431 💬 2件: DRD1, DRD5 💬 10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 1件:  6  💬
86 7-beta-hydroxyepiandrosterone 7-beta-Hydroxyepiandrosterone - - - 1件:  6  💬
87 75 - - - - 1件:  6  💬
88 8-ohdg 8-hydroxy-2'-deoxyguanosine - - - 1件:  6  💬
89 [11c]pbr28 - - - - 1件:  6  💬
90 [11c]pxt012253 - - - - 1件:  6  💬
91 [11c]smw139 - - - - 1件:  6  💬
92 [123i] 5-ia - - - - 1件:  6  💬
93 [123i] ibvm and spect imaging - - - - 1件:  6  💬
94 [123i] mzint injection and serial dynamic spect imaging - - - - 1件:  6  💬
95 [123i]-ibvm - - - - 1件:  6  💬
96 [123i]b-cit - - - - 1件:  6  💬
97 [123i]b-cit spect imaging - - - - 1件:  6  💬
98 [123i]beta cit - - - - 1件:  6  💬
99 [123i]beta cit and spect imaging - - - - 1件:  6  💬
100 [123i]beta-cit - - - - 1件:  6  💬
101 [123i]beta-cit and spect imaging - - - - 1件:  6  💬
102 [123i]clinde - - - - 2件:  6 , 13 💬
103 [123i]mni-420 - - - - 2件:  6 ,  8  💬
104 [123i]ß cit - - - - 1件:  6  💬
105 [123i]ß cit and spect imaging - - - - 1件:  6  💬
106 [123i]ß-cit - - - - 1件:  6  💬
107 [123i]ß-cit and spect imaging - - - - 1件:  6  💬
108 [14c]-bia 9-1067 BIA - - - 1件:  6  💬
109 [15o]h2o - - - - 1件:  6  💬
110 [18f] cfpypb - - - - 1件:  6  💬
111 [18f] lbt-999 - - - - 1件:  6  💬
112 [18f] lbt-999 pet - - - - 1件:  6  💬
113 [18f] pbr06 - - - - 2件:  6 , 13 💬
114 [18f]-(e)-n-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane - - - - 1件:  6  💬
115 [18f]-feppa - - - - 2件:  6 , 13 💬
116 [18f]dpa-714 pet scan - - - - 1件:  6  💬
117 [18f]fdopa - - - - 2件:  6 , 17 💬
118 [18f]fdopa pet/ct - - - - 1件:  6  💬
119 [18f]fe-pe2i - - - - 1件:  6  💬
120 [18f]fpeb - - - - 3件:  6 ,  8 , 206 💬
121 [18f]mk-9470 - - - - 1件:  6  💬
122 [18f]mni-1126 - - - - 1件:  6  💬
123 [18f]mppf - - - - 1件:  6  💬
124 [18f]nos - - - - 1件:  6  💬
125 [18f]p17-059 - - - - 1件:  6  💬
126 [18f]pi-2620 - - - - 2件:  6 , 127 💬
127 [18f]t807 ([18f]mni-777) - - - - 2件:  5 ,  6  💬
128 [21cfr640.30] plasma from 18 - 25 year old volunteer donors - - - - 1件:  6  💬
129 [abbv-951] - - - - 1件:  6  💬
130 [f-18] fluorodopa positron emission tomography - - - - 1件:  6  💬
131 [jnj31-31001074] - - - - 1件:  6  💬
132 [na] - - - - 7件:  6 , 11, 35, 46, 53, 65, 299 💬
133 A-dopamine Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
134 Aav2-gdnf - - - - 1件:  6  💬
135 Ab1010 - - - - 6件:  2 ,  5 ,  6 , 13, 46, 96 💬
136 Abbv-0805 - - - - 1件:  6  💬
137 Abbv-951 - - - - 1件:  6  💬
138 Abt-slv187 - - - - 1件:  6  💬
139 Acamprosate Acamprosate 2件: D02780, D07058 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 2件:  6 , 206 💬
140 Accordion pill carbidopa/levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
141 Accordion pill ¿ carbidopa/levodopa 50/400 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
142 Accordion pill ¿ carbidopa/levodopa 50/500 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
143 Accordion pill? carbidopa/levodopa 50/400 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
144 Accordion pill? carbidopa/levodopa 50/500 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
145 Accordion pill™ carbidopa/levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
146 Accordion pill™ carbidopa/levodopa 50/400 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
147 Accordion pill™ carbidopa/levodopa 50/500 mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
148 Acetate Acetate - - - 43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
149 Acetylcysteine Acetylcysteine 1件: D00221 💬 - - 16件:  6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬
150 Acp-103 - - - - 1件:  6  💬
151 Acr325 ACR325 - - - 1件:  6  💬
152 Active comparator - - - - 2件:  6 , 46 💬
153 Active drug (biib014) at 10, 30, 100, or 300 mg once daily. - - - - 1件:  6  💬
154 Active drug: pimavanserin 17mg (2 strength tablets) Pimavanserin - - - 1件:  6  💬
155 Active investigational treatment ent-01 - - - - 1件:  6  💬
156 Ad-810n (zonisamide) Zonisamide 1件: D00538 💬 8件: CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 1件:  6  💬
157 Adjuvant without active component - - - - 2件:  6 , 17 💬
158 Administration of stable isotope-labelled leucine- Leucine 1件: D00030 💬 - - 1件:  6  💬
159 Ads-5102 - - - - 2件:  6 , 13 💬
160 Ads-5102 (extended release amantadine hcl) Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
161 Adx48621 - - - - 1件:  6  💬
162 Affitope® pd01a - - - - 1件:  6  💬
163 Affitope® pd01a + adjuvant - - - - 2件:  6 , 17 💬
164 Afq056 - - - - 3件:  6 ,  8 , 206 💬
165 Afq056 with l-dopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
166 Afq065 - - - - 1件:  6  💬
167 Agomelatine Agomelatine 1件: D02578 💬 3件: HTR2C, MTNR1A, MTNR1B 💬 6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 1件:  6  💬
168 Agomelatine or piacebo Agomelatine 1件: D02578 💬 3件: HTR2C, MTNR1A, MTNR1B 💬 6件: Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 1件:  6  💬
169 Aha - - - - 1件:  6  💬
170 Akst4290 - - - - 2件:  6 , 162 💬
171 Al - - - - 9件:  5 ,  6 ,  7 , 28, 51, 67, 86, 114, 127 💬
172 Alanine Alanine 1件: D00012 💬 - - 4件:  6 , 13, 298, 299 💬
173 Allogeneic bone marrow-derived mscs (1 x 10 6 msc/kg) - - - - 1件:  6  💬
174 Allogeneic bone marrow-derived mscs (10 x 10 6 msc/kg) - - - - 1件:  6  💬
175 Allogeneic bone marrow-derived mscs (3 x 10 6 msc/kg) - - - - 1件:  6  💬
176 Allogeneic bone marrow-derived mscs (6 x 10 6 msc/kg) - - - - 1件:  6  💬
177 Allopurinol Allopurinol 1件: D00224 💬 1件: XDH 💬 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 6件:  6 , 46, 57, 66, 96, 97 💬
178 Altropane Altropane - - - 1件:  6  💬
179 Altropane® Altropane - - - 1件:  6  💬
180 Amantadin-ratiopharm 100mg - - - - 1件:  6  💬
181 Amantadine Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 4件:  6 ,  8 , 13, 127 💬
182 Amantadine 300 mg Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
183 Amantadine hcl er Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
184 Amantadine hcl extended release Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
185 Amantadine hcl extended release capsule Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
186 Amantadine hydrochloride Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
187 Amantadine hydrochloride (hcl) Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
188 Amantadine sulfate Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
189 Ambrosan 60mg tablets - - - - 1件:  6  💬
190 Ambroxol Ambroxol 1件: D07442 💬 - - 2件:  6 , 19 💬
191 Ambroxol hydrochloride Ambroxol 1件: D07442 💬 - - 1件:  6  💬
192 Ammonia Ammonia 1件: D02916 💬 - - 4件:  6 , 17, 86, 88 💬
193 Amoxicillin Amoxicillin 3件: D00229, D02925, D07452 💬 - - 7件:  6 , 46, 63, 96, 97, 222, 299 💬
194 Ampreloxetine Ampreloxetine 1件: D11688 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 17 💬
195 Ampreloxetine chydrochloride Ampreloxetine 1件: D11688 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 17 💬
196 Ampreloxetine hydrochloride Ampreloxetine 1件: D11688 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 17 💬
197 Ampyra - - - - 2件:  6 , 13 💬
198 Ampyra first, - - - - 1件:  6  💬
199 Anavex2-73 - - - - 2件:  6 , 156 💬
200 Anhydrous carbidopa Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
201 Anti-parkinson medication - - - - 5件:  5 ,  6 ,  7 ,  8 , 17 💬
202 Antiparkinsonian agent(s) - - - - 1件:  6  💬
203 Ap - - - - 4件:  2 ,  6 , 13, 299 💬
204 Ap-cd/ld - - - - 1件:  6  💬
205 Ap09004 - - - - 1件:  6  💬
206 Apl-130277 - - - - 1件:  6  💬
207 Aplindore Aplindore - - - 1件:  6  💬
208 Aplindore mr tablets Aplindore - - - 1件:  6  💬
209 Apo-go - - - - 1件:  6  💬
210 Apo-go® - - - - 1件:  6  💬
211 Apokinon - - - - 1件:  6  💬
212 Apokyn - - - - 1件:  6  💬
213 Apomor - - - - 1件:  6  💬
214 Apomorp - - - - 1件:  6  💬
215 Apomorphine Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
216 Apomorphine 0.25% (2.5mg/ml) Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
217 Apomorphine hcl injection Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
218 Apomorphine hydrochloride Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
219 Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
220 Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
221 Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
222 Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
223 Apomorphine hydrochloride hemihydrate Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
224 Apomorphine hydrocloride Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
225 Apomorphine hydrocloride hemihydrate Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
226 Apomorphine infusion Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
227 Apomorphine nasal powder Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
228 Aporon - - - - 1件:  6  💬
229 Aqw051 - - - - 1件:  6  💬
230 Aricept - - - - 4件:  6 , 13, 78, 124 💬
231 Aricept 5 mg-filmtabletten - - - - 1件:  6  💬
232 Aricept 5mg-filmtabletten - - - - 1件:  6  💬
233 Aripiprazole Aripiprazole 1件: D01164 💬 4件: DRD2, DRD3, HTR1A, HTR2A 💬 12件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 2件:  6 , 206 💬
234 Armodafinil Armodafinil 1件: D03215 💬 1件: SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 3件:  6 , 13, 84 💬
235 Artane - - - - 1件:  6  💬
236 As2 - - - - 1件:  6  💬
237 Asyn mab - - - - 1件:  6  💬
238 At 10 - - - - 1件:  6  💬
239 Atm fog in pd - - - - 1件:  6  💬
240 Atomoxetine Atomoxetine 2件: D02574, D07473 💬 1件: SLC6A2 💬 1件: Synaptic vesicle cycle 3件:  6 ,  8 , 13 💬
241 Atypical antipsychotics - - - - 1件:  6  💬
242 Autologous mesenchymal stem cells - - - - 5件:  2 ,  6 , 13, 17, 46 💬
243 Av-101 AV-101 - - - 1件:  6  💬
244 Avalox - - - - 1件:  6  💬
245 Avalox - 400 mg compresse rivestite con film 5 compresse in blister pp/al - - - - 1件:  6  💬
246 Ave8112 - - - - 1件:  6  💬
247 Avp-923 - - - - 3件:  2 ,  6 , 13 💬
248 Avp-923-45 - - - - 1件:  6  💬
249 Azathioprine Azathioprine 2件: D00238, D03033 💬 - - 20件:  6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬
250 Azd3241 - - - - 2件:  6 , 17 💬
251 Azd3241 300 mg bid - - - - 1件:  6  💬
252 Azd3241 600 mg bid - - - - 1件:  6  💬
253 Azd3241 alternative titration scheme with formulation 1 or 2 - - - - 1件:  6  💬
254 Azd3241 er formulation 1 - - - - 1件:  6  💬
255 Azd3241 extended release tablets 100 mg - - - - 1件:  6  💬
256 Azd3241 extended release tablets 25 mg - - - - 1件:  6  💬
257 Azilect - - - - 4件:  2 ,  5 ,  6 , 17 💬
258 Azilect 1 mg comprimidos - - - - 2件:  6 , 17 💬
259 Azilect 1mg - - - - 1件:  6  💬
260 Azilect® - - - - 1件:  6  💬
261 B-cit and spect imaging - - - - 1件:  6  💬
262 B6, b12, l-methylfolate Levomefolic acid 1件: D09353 💬 - - 1件:  6  💬
263 Balance Isoxaflutole - - - 9件:  5 ,  6 , 13, 46, 81, 113, 122, 149, 299 💬
264 Band - - - - 2件:  6 , 97 💬
265 Bavisant Bavisant 1件: D09870 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
266 Bavisant dihydrochloride monohydrate Bavisant 1件: D09870 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
267 Bavisant hydrochloride monohydrate Bavisant 1件: D09870 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
268 Beam Tricyclazole - - - 2件:  6 , 51 💬
269 Bee venom - - - - 1件:  6  💬
270 Behavioral: assessment of cognition - - - - 1件:  6  💬
271 Behavioral: assessment of depression - - - - 1件:  6  💬
272 Behavioral: assessment of motor and non-motors symptoms of pd evaluation of hyper- and hypodopaminergic behaviors - - - - 1件:  6  💬
273 Behavioral: assessment of quality of life - - - - 1件:  6  💬
274 Behavioral: assessment of severity of icd (impulse control disorders) - - - - 1件:  6  💬
275 Behavioral: assessment of severity of parkinson disease - - - - 1件:  6  💬
276 Behavioral: attention control - - - - 1件:  6  💬
277 Behavioral: augmented reality multi-modal training - - - - 1件:  6  💬
278 Behavioral: balance & strengthening exercises Isoxaflutole - - - 1件:  6  💬
279 Behavioral: balance training Isoxaflutole - - - 2件:  6 , 13 💬
280 Behavioral: bci-fit active querying - - - - 3件:  2 ,  6 , 17 💬
281 Behavioral: bci-fit adaptive signal modeling - - - - 3件:  2 ,  6 , 17 💬
282 Behavioral: bci-fit language modeling - - - - 3件:  2 ,  6 , 17 💬
283 Behavioral: bci-fit multi-modal access - - - - 3件:  2 ,  6 , 17 💬
284 Behavioral: brisk walking and balance training Isoxaflutole - - - 1件:  6  💬
285 Behavioral: building better caregivers workshop - - - - 1件:  6  💬
286 Behavioral: cbt and sleep hygiene - - - - 1件:  6  💬
287 Behavioral: co-op treatment protocol - - - - 1件:  6  💬
288 Behavioral: cognitive and behavioral experimental tasks - - - - 2件:  6 , 127 💬
289 Behavioral: combined balance and brisk walking training Isoxaflutole - - - 1件:  6  💬
290 Behavioral: conservative measures for orthostatic hypotension - - - - 2件:  6 , 17 💬
291 Behavioral: dexterity - - - - 1件:  6  💬
292 Behavioral: dual task - - - - 1件:  6  💬
293 Behavioral: ecocapture - - - - 2件:  6 , 127 💬
294 Behavioral: emotion assessment - - - - 1件:  6  💬
295 Behavioral: exercise - - - - 3件:  6 , 265, 299 💬
296 Behavioral: exercise only - - - - 1件:  6  💬
297 Behavioral: exercise+multi-modal sensory feedback (mmsf) - - - - 1件:  6  💬
298 Behavioral: flexibility and strengthening exercise - - - - 1件:  6  💬
299 Behavioral: gait and balance Isoxaflutole - - - 1件:  6  💬
300 Behavioral: gait and balance training program Isoxaflutole - - - 1件:  6  💬
301 Behavioral: healthy age-matched controls - - - - 1件:  6  💬
302 Behavioral: icm_apathy_tasks - - - - 2件:  6 , 127 💬
303 Behavioral: levodopa or acupuncture Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
304 Behavioral: low-impact exercise control - - - - 1件:  6  💬
305 Behavioral: memory - - - - 1件:  6  💬
306 Behavioral: participant open-response writing - - - - 1件:  6  💬
307 Behavioral: participant self-assessment surveys - - - - 1件:  6  💬
308 Behavioral: pat sessions - - - - 1件:  6  💬
309 Behavioral: pelvic floor muscle exercise-based behavioral therapy - - - - 1件:  6  💬
310 Behavioral: phonation - - - - 1件:  6  💬
311 Behavioral: physical exam and updrs part iii assessment - - - - 1件:  6  💬
312 Behavioral: physical therapy - - - - 1件:  6  💬
313 Behavioral: resistance training - - - - 1件:  6  💬
314 Behavioral: rest - - - - 1件:  6  💬
315 Behavioral: role of dopamine Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
316 Behavioral: single task - - - - 1件:  6  💬
317 Behavioral: strength training - - - - 1件:  6  💬
318 Behavioral: stretching - - - - 1件:  6  💬
319 Behavioral: tai chi - - - - 1件:  6  💬
320 Behavioral: traditional multi-modal training - - - - 1件:  6  💬
321 Behavioral: upper limb exercise - - - - 1件:  6  💬
322 Ben-2001 - - - - 1件:  6  💬
323 Benserazide Benserazide 1件: D03082 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
324 Benserazide hydrochloride Benserazide 1件: D03082 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
325 Benzofuran Benzofuran - - - 1件:  6  💬
326 Berachin - - - - 1件:  6  💬
327 Best medical treatment - - - - 1件:  6  💬
328 Best médical treatment - - - - 1件:  6  💬
329 Betaquik mct supplement - - - - 1件:  6  💬
330 Better - - - - 1件:  6  💬
331 Bf 2.649 - - - - 1件:  6  💬
332 Bf 2.649 10 mg - - - - 1件:  6  💬
333 Bf 2.649 20 mg - - - - 1件:  6  💬
334 Bf 2.649 40 mg - - - - 1件:  6  💬
335 Bf 2.649 5 mg - - - - 1件:  6  💬
336 Bf2.649 - - - - 1件:  6  💬
337 Bf2.649 (pitolisant) Pitolisant 1件: D10749 💬 1件: HRH3 💬 1件: Neuroactive ligand-receptor interaction 1件:  6  💬
338 Bi-sifrol® - - - - 1件:  6  💬
339 Bia BIA - - - 2件:  6 , 86 💬
340 Bia 3-202 BIA - - - 1件:  6  💬
341 Bia 3-202 (200 mg) BIA - - - 1件:  6  💬
342 Bia 6-512 BIA - - - 1件:  6  💬
343 Bia 6-512 100 mg BIA - - - 1件:  6  💬
344 Bia 6-512 100 mg dose BIA - - - 1件:  6  💬
345 Bia 6-512 200 mg dose BIA - - - 1件:  6  💬
346 Bia 6-512 25 mg BIA - - - 1件:  6  💬
347 Bia 6-512 25 mg dose BIA - - - 1件:  6  💬
348 Bia 6-512 400 mg BIA - - - 1件:  6  💬
349 Bia 6-512 50 mg dose BIA - - - 1件:  6  💬
350 Bia 9-1067 BIA - - - 1件:  6  💬
351 Bia 9-1067 (test) BIA - - - 1件:  6  💬
352 Bia 9-1067 15 mg BIA - - - 1件:  6  💬
353 Bia 9-1067 25 mg BIA - - - 1件:  6  💬
354 Bia 9-1067 30 mg BIA - - - 1件:  6  💬
355 Bia 9-1067 5 mg BIA - - - 1件:  6  💬
356 Bia 9-1067 micronized BIA - - - 1件:  6  💬
357 Bia 9-1067 non-micronized BIA - - - 1件:  6  💬
358 Biib014 - - - - 1件:  6  💬
359 Biib054 - - - - 1件:  6  💬
360 Biib094 - - - - 1件:  6  💬
361 Bisphosphonates - - - - 2件:  6 , 274 💬
362 Bone marrow derived mesenchymal stem cells - - - - 2件:  6 , 60 💬
363 Bont-a - - - - 1件:  6  💬
364 Botox - - - - 6件:  2 ,  6 , 13, 51, 149, 226 💬
365 Botulinum toxin - - - - 3件:  6 , 13, 149 💬
366 Botulinum toxin type a Botulinum toxin type A 1件: D00783 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 10件:  2 ,  5 ,  6 ,  7 , 13, 15, 17, 70, 113, 149 💬
367 Botulinum toxin type b Botulinum Toxin Type B 1件: D02735 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 3件:  2 ,  6 , 51 💬
368 Botulinum toxin type b (myobloc) Botulinum Toxin Type B 1件: D02735 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 2件:  2 ,  6  💬
369 Botulinum toxin: xeomin - - - - 1件:  6  💬
370 Bromocriptine Bromocriptine 2件: D00780, D03165 💬 2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 2件:  6 , 74 💬
371 Bromocriptine and other dopamine agonists Bromocriptine 4件: D00633, D00780, D03165, D07870 💬 6件: DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 15件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
372 Btrx-246040 BTRX-246040 - - - 1件:  6  💬
373 Btx-a Botulinum toxin type A 1件: D00783 💬 1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 1件:  6  💬
374 Bumetanide Bumetanide 1件: D00247 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 2件:  6 , 158 💬
375 Bumetanide white, oblong, scored tablet Bumetanide 1件: D00247 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 1件:  6  💬
376 Bupleurum+ginkgo Ginkgo biloba - - - 1件:  6  💬
377 Buspirone Buspirone 2件: D00702, D07593 💬 2件: DRD2, HTR1A 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 2件:  6 , 51 💬
378 Buspirone hydrochloride Buspirone 2件: D00702, D07593 💬 2件: DRD2, HTR1A 💬 10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 1件:  6  💬
379 Butylphthalide Butylphthalide - - - 4件:  2 ,  6 , 18, 22 💬
380 Bydureon - - - - 2件:  6 , 17 💬
381 Bydureon 2 mg powder and solvent for prolonged-release suspension - - - - 1件:  6  💬
382 Byetta - - - - 2件:  6 , 193 💬
383 Byetta 5 micrograms - - - - 1件:  6  💬
384 Cabaser - - - - 1件:  6  💬
385 Cabaseril - - - - 1件:  6  💬
386 Cabaseril, 1,0 mg tablette - - - - 1件:  6  💬
387 Cabaseril, 2,0 mg tablette - - - - 1件:  6  💬
388 Cabergolina Cabergoline 1件: D00987 💬 2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
389 Cabergoline Cabergoline 1件: D00987 💬 2件: DRD2, PRL 💬 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 3件:  6 , 74, 75 💬
390 Caffeine Caffeine 2件: D00528, D01453 💬 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 9件:  2 ,  6 , 13, 21, 46, 78, 96, 97, 265 💬
391 Caffeine 100-200 mg bid Caffeine 2件: D00528, D01453 💬 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
392 Caffeine alkaloid Caffeine 2件: D00528, D01453 💬 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
393 Calcium Calcium - - - 27件:  6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
394 Cannabidiol Cannabidiol 1件: D10915 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 17件:  6 ,  8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬
395 Cannabidiol (cbd) Cannabidiol 1件: D10915 💬 2件: CNR1, CNR2 💬 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 6件:  6 , 140, 144, 145, 156, 158 💬
396 Cannabis Medical Cannabis - - - 8件:  2 ,  6 , 13, 46, 90, 96, 97, 271 💬
397 Cannabis oil Medical Cannabis - - - 1件:  6  💬
398 Cannabis, medical Medical Cannabis - - - 5件:  2 ,  6 , 13, 96, 97 💬
399 Capsaicin Capsaicin 1件: D00250 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 5件:  2 ,  6 , 19, 86, 226 💬
400 Capsaicin vapor Capsaicin 1件: D00250 💬 1件: TRPV1 💬 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 1件:  6  💬
401 Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
402 Capture Bifenthrin - - - 2件:  6 , 46 💬
403 Carbidopa Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
404 Carbidopa (fu) Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
405 Carbidopa 20 mg Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
406 Carbidopa 200mg oral dose Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 2件:  6 , 17 💬
407 Carbidopa 27.5 mg Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
408 Carbidopa 65 mg capsule Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
409 Carbidopa and levodopa 25mg/100mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
410 Carbidopa and levodopa tablets, usp Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
411 Carbidopa anidra Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
412 Carbidopa fu Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
413 Carbidopa inn Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
414 Carbidopa levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
415 Carbidopa monohydrate Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
416 Carbidopa, levodopa, entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
417 Carbidopa- levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
418 Carbidopa-4'-monophosphate Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
419 Carbidopa-levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 3件:  2 ,  4 ,  6  💬
420 Carbidopa-levodopa 25 mg-100 mg oral tablet Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
421 Carbidopa/l-dopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
422 Carbidopa/l-dopa/entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
423 Carbidopa/levodopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
424 Carbidopa/levodopa, immediate release Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
425 Carbidopa/levodopa/entacapone Carbidopa 3件: D00059, D00558, D00781 💬 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
426 Carbidopamonohydraat - - - - 1件:  6  💬
427 Carbodopa levadopa - - - - 1件:  6  💬
428 Carbodopa/levadopa - - - - 1件:  6  💬
429 Carbon Activated charcoal 1件: D03251 💬 - - 9件:  6 , 46, 50, 51, 85, 86, 96, 97, 298 💬
430 Carnosine Carnosine - - - 2件:  6 , 13 💬
431 Carnosine supplementation Carnosine - - - 1件:  6  💬
432 Carvedilol Carvedilol 2件: D00255, D03415 💬 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 5件:  6 , 57, 86, 113, 210 💬
433 Catapres ampoules - - - - 1件:  6  💬
434 Catapressan - - - - 1件:  6  💬
435 Cbd - - - - 11件:  2 ,  6 ,  8 , 13, 46, 140, 144, 145, 156, 158, 206 💬
436 Cd - - - - 6件:  6 , 46, 51, 96, 97, 265 💬
437 Cd-ld cr - - - - 1件:  6  💬
438 Cd-ld ir - - - - 1件:  6  💬
439 Cdnf - - - - 1件:  6  💬
440 Ceftriaxone Ceftriaxone 2件: D00924, D07659 💬 - - 3件:  2 ,  6 , 97 💬
441 Cep-1347 CEP-1347 - - - 1件:  6  💬
442 Cep-1347 10mg CEP-1347 - - - 1件:  6  💬
443 Cep-1347 50mg CEP-1347 - - - 1件:  6  💬
444 Cep1347 - - - - 1件:  6  💬
445 Cep1347 25mg - - - - 1件:  6  💬
446 Cere-120 - - - - 1件:  6  💬
447 Cere-120 (adeno-associated virus serotype 2 [aav2]-neurturin [ntn]) - - - - 1件:  6  💬
448 Cere-120: adeno-associated virus delivery of neurturin - - - - 1件:  6  💬
449 Cerebral dopamine neurotrophic factor Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
450 Ceretec - - - - 1件:  6  💬
451 Ceretec (tm) estabilizado - - - - 1件:  6  💬
452 Champix - - - - 1件:  6  💬
453 Chloride Chloride ion - - - 25件:  6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬
454 Chocolate Cocoa - - - 1件:  6  💬
455 Cipralex - - - - 1件:  6  💬
456 Circadin - - - - 3件:  6 , 13, 90 💬
457 Circadin® - - - - 1件:  6  💬
458 Citalopram Citalopram 2件: D00822, D07704 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 6件:  6 ,  8 , 13, 18, 46, 127 💬
459 Citalopram 20mg Citalopram 2件: D00822, D07704 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
460 Cjh1 (clr4001) - - - - 1件:  6  💬
461 Clarithromycin Clarithromycin 1件: D00276 💬 - - 8件:  6 , 63, 84, 96, 97, 222, 228, 299 💬
462 Clarithromycin (not used as of 4/2020) Clarithromycin 1件: D00276 💬 - - 1件:  6  💬
463 Clarium 50 mg retardtabletten - - - - 1件:  6  💬
464 Clartihromycin, amoxicillin, and omeprazole Amoxicillin 7件: D00229, D00455, D01207, D02925, D05259, D05261, D07452 💬 2件: ATP4A, ATP4B 💬 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 1件:  6  💬
465 Cle - - - - 1件:  6  💬
466 Clenbuterol Clenbuterol 1件: D07713 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 4件:  1 ,  2 ,  6 , 256 💬
467 Clenbuterol hcl Clenbuterol 1件: D07713 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
468 Clenbuterol hydrochloride Clenbuterol 1件: D07713 💬 1件: ADRB2 💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
469 Clonazepam Clonazepam 1件: D00280 💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 1件:  6  💬
470 Clonidine Clonidine 2件: D00281, D00604 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 2件:  6 , 78 💬
471 Clonidine hydrochloride Clonidine 2件: D00281, D00604 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 2件:  6 , 78 💬
472 Clozapine Clozapine 1件: D00283 💬 11件: ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 8件: Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 1件:  6  💬
473 Co - - - - 5件:  6 , 13, 53, 70, 85 💬
474 Cocoa Cocoa - - - 1件:  6  💬
475 Coenzyme q10 Ubidecarenone 1件: D01065 💬 - - 12件:  2 ,  5 ,  6 ,  8 , 10, 18, 46, 57, 113, 193, 214, 215 💬
476 Coenzyme q10 nanodispersion (nanoquinone) Ubidecarenone 1件: D01065 💬 - - 1件:  6  💬
477 Coenzyme q10 with vitamin e Ubidecarenone 2件: D01065, D02331 💬 - - 1件:  6  💬
478 Cofactor - - - - 3件:  6 , 265, 288 💬
479 Cogane - - - - 1件:  6  💬
480 Cogane™ (pym50028) - - - - 1件:  6  💬
481 Cohort 1:nilotinib oral capsules (150mg or 300mg) Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
482 Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1) Nilotinib 1件: D08953 💬 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 1件:  6  💬
483 Combination injection of epo and g-csf Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件:  6  💬
484 Combination product: l-dopa 140 mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
485 Combination product: l-dopa 35 mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
486 Combination product: l-dopa 70mg Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
487 Combination product: l-dopa 70mg/carbidopa 7mg Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
488 Combination product: nd0612 solution for sc infusion - - - - 1件:  6  💬
489 Comparator: carbidopa Carbidopa 1件: D00558 💬 1件: DDC 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 1件:  6  💬
490 Comparator: levodopa Levodopa 1件: D00059 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
491 Comtan - - - - 1件:  6  💬
492 Comtan 200* 60 cpr 200 mg - - - - 1件:  6  💬
493 Comtan® - - - - 1件:  6  💬
494 Comtanâ® - - - - 1件:  6  💬
495 Comtess - - - - 1件:  6  💬
496 Comtess® - - - - 1件:  6  💬
497 Continuous apomorphine infusion Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
498 Continuous intrajejunal infusion of levodopa-carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
499 Continuous release dopamine agonists Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
500 Continuous subcutaneous lisuride infusion Lisuride 2件: D01462, D08132 💬 3件: DRD2, DRD3, DRD4 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
501 Control - - - - 4件:  6 , 46, 168, 299 💬
502 Controlled-release levodopa / carbidopa Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
503 Coq10 - - - - 3件:  5 ,  6 ,  8  💬
504 Cord blood therapy Umbilical Cord Blood Hematopoietic Stem Cells - - - 2件:  2 ,  6  💬
505 Cortef - - - - 3件:  6 , 81, 83 💬
506 Cp - - - - 6件:  6 , 46, 96, 97, 107, 271 💬
507 Creatine Creatine - - - 12件:  1 ,  2 ,  5 ,  6 ,  8 , 13, 46, 49, 50, 113, 156, 201 💬
508 Cst-103 - - - - 1件:  6  💬
509 Cst-139 - - - - 1件:  6  💬
510 Cu(ii)atsm - - - - 2件:  2 ,  6  💬
511 Cvd00118-e - - - - 1件:  6  💬
512 Cvl-751 - - - - 1件:  6  💬
513 Cvn424 high dose - - - - 1件:  6  💬
514 Cvn424 low dose - - - - 1件:  6  💬
515 Cvt-301 - - - - 1件:  6  💬
516 Cvt-301 (dose level 1) - - - - 1件:  6  💬
517 Cvt-301 (dose level 2) - - - - 1件:  6  💬
518 Cvt-301 35mg - - - - 1件:  6  💬
519 Cvt-301 50mg - - - - 1件:  6  💬
520 Cvt-301 high dose - - - - 1件:  6  💬
521 Cvt-301 low dose - - - - 1件:  6  💬
522 Cvt-301, lip - - - - 1件:  6  💬
523 Cvxl-0107 - - - - 1件:  6  💬
524 Cx-8998 - - - - 1件:  6  💬
525 Cyberknife - - - - 1件:  6  💬
526 Cymbalta - - - - 3件:  6 , 13, 49 💬
527 Cysteine Cysteine 2件: D00026, D02326 💬 - - 11件:  6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬
528 Cystoscopic injection of botox into the urinary bladder - - - - 1件:  6  💬
529 D-serine D-Serine 1件: D00016 💬 - - 1件:  6  💬
530 D-serine (~2g/day) D-Serine 1件: D00016 💬 - - 1件:  6  💬
531 Da-9701 - - - - 1件:  6  💬
532 Da-9805 45mg - - - - 1件:  6  💬
533 Da-9805 90mg - - - - 1件:  6  💬
534 Daaoi-p - - - - 1件:  6  💬
535 Dacepton 5 mg/ml - - - - 1件:  6  💬
536 Dacepton 5 mg/ml infuusioneste, liuos - - - - 1件:  6  💬
537 Daily ingestion of lactobacillus plantarum ps128 Lactobacillus plantarum - - - 1件:  6  💬
538 Darifenacin Darifenacin 2件: D01699, D03654 💬 1件: CHRM3 💬 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 2件:  6 , 13 💬
539 Dark chocolate (85% cocoa) Cocoa - - - 1件:  6  💬
540 Datscan - - - - 4件:  2 ,  5 ,  6 , 17 💬
541 Datscan 74 mbq/ml solution for injection - - - - 1件:  6  💬
542 Datscan™ - - - - 1件:  6  💬
543 Datscan™ ioflupane (123i) injection - - - - 3件:  5 ,  6 , 17 💬
544 Dc158am - - - - 1件:  6  💬
545 Dci - - - - 2件:  6 , 299 💬
546 Dcs - - - - 1件:  6  💬
547 Deanol Deanol 1件: D07777 💬 - - 1件:  6  💬
548 Deanol pyroglutamate Deanol 1件: D07777 💬 - - 1件:  6  💬
549 Debrumyl - - - - 1件:  6  💬
550 Deferiprone Deferiprone 1件: D07416 💬 - - 6件:  2 ,  6 , 18, 120, 122, 233 💬
551 Deferiprone (ferriprox) Deferiprone 1件: D07416 💬 - - 1件:  6  💬
552 Deferiprone 20mg Deferiprone 1件: D07416 💬 - - 1件:  6  💬
553 Deferiprone 30mg Deferiprone 1件: D07416 💬 - - 1件:  6  💬
554 Deferiprone 600 mg delayed release tablet Deferiprone 1件: D07416 💬 - - 1件:  6  💬
555 Deferiprone dr Deferiprone 1件: D07416 💬 - - 1件:  6  💬
556 Desipramine Desipramine 2件: D00812, D07791 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 4件:  6 , 17, 120, 156 💬
557 Desipramine (dmi) Desipramine 2件: D00812, D07791 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 17 💬
558 Desmopressin Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 5件:  6 , 64, 72, 225, 288 💬
559 Desmopressin acetat Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 1件:  6  💬
560 Desmotabs - - - - 1件:  6  💬
561 Desmotabs® 0,2 mg tabletten - - - - 1件:  6  💬
562 Desmotabs® 0,2mg tabletten - - - - 1件:  6  💬
563 Determination of drug effects through amantadine cessation Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
564 Device: abdominal compression - - - - 2件:  6 , 17 💬
565 Device: actimyo recording - - - - 1件:  6  💬
566 Device: active tdcs - - - - 1件:  6  💬
567 Device: active tpcs - - - - 1件:  6  💬
568 Device: adaptor: hakko adaptor - - - - 1件:  6  💬
569 Device: aha exergame system - - - - 1件:  6  💬
570 Device: b-stn dbs - - - - 1件:  6  💬
571 Device: balance training Isoxaflutole - - - 1件:  6  💬
572 Device: balance training with nintendo wii fit Isoxaflutole - - - 1件:  6  💬
573 Device: cadd-legacy ambulatory infusion pump - - - - 1件:  6  💬
574 Device: cadd-legacy® 1400 ambulatory infusion pump - - - - 1件:  6  💬
575 Device: carbon fiber ankle foot orthosis (afo) Activated charcoal 1件: D03251 💬 - - 1件:  6  💬
576 Device: clonidine (catapressan) Clonidine 2件: D00281, D00604 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件:  6  💬
577 Device: deep brain stimulation - - - - 5件:  5 ,  6 ,  7 ,  8 , 17 💬
578 Device: functional magnetic resonance imaging - - - - 1件:  6  💬
579 Device: infusion pump: cadd-legacy® 1400 pump - - - - 1件:  6  💬
580 Device: inspiratory muscle training - - - - 1件:  6  💬
581 Device: j-tube - - - - 1件:  6  💬
582 Device: jejunal extension tube - - - - 1件:  6  💬
583 Device: jejunal extension tube (j-tube) - - - - 1件:  6  💬
584 Device: kinetra and soletra (neurostimulator, medtronic) - - - - 1件:  6  💬
585 Device: light box ( litebook company) - - - - 1件:  6  💬
586 Device: light box (litebook company) - - - - 1件:  6  💬
587 Device: magnetic resonance imaging - - - - 5件:  6 , 13, 22, 34, 299 💬
588 Device: massage with a spiky ball - - - - 1件:  6  💬
589 Device: ms band 2 - - - - 1件:  6  💬
590 Device: nebulizer - - - - 1件:  6  💬
591 Device: nj-tube: silicon ed tube Silicon - - - 1件:  6  💬
592 Device: oct - tce - - - - 1件:  6  💬
593 Device: peg tube - - - - 1件:  6  💬
594 Device: percutaneous endoscopic gastrostomy tube - - - - 1件:  6  💬
595 Device: percutaneous endoscopic gastrostomy tube (peg tube) - - - - 1件:  6  💬
596 Device: renishaw drug delivery system - - - - 1件:  6  💬
597 Device: resistive respiratory loads - - - - 1件:  6  💬
598 Device: sham compression - - - - 2件:  6 , 17 💬
599 Device: sham tdcs - - - - 1件:  6  💬
600 Device: sham tpcs - - - - 1件:  6  💬
601 Device: spect imaging - - - - 1件:  6  💬
602 Device: spoton balance glasses Isoxaflutole - - - 1件:  6  💬
603 Device: stimulator off - - - - 1件:  6  💬
604 Device: stimulator on - - - - 1件:  6  💬
605 Dexdor - - - - 4件:  2 ,  4 ,  6 , 70 💬
606 Dexmedetomidina Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件:  6  💬
607 Dexmedetomidine Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 12件:  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
608 Dexmedetomidine hydrochloride infusion Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件:  6  💬
609 Dextromethorphan Dextromethorphan 3件: D00848, D03742, D03744 💬 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 11件:  2 ,  6 ,  8 , 13, 21, 46, 78, 85, 96, 97, 156 💬
610 Dha - - - - 8件:  6 , 46, 48, 49, 94, 113, 299, 301 💬
611 Diagnostic test: [18f]-ro6958948 - - - - 5件:  5 ,  6 ,  7 , 17, 127 💬
612 Diagnostic test: auto-assessment manikins (sam) - - - - 1件:  6  💬
613 Diagnostic test: barcelona test (bt) - - - - 1件:  6  💬
614 Diagnostic test: beam test to predict falls Tricyclazole - - - 1件:  6  💬
615 Diagnostic test: beck depression inventory-ii (bdi-ii) - - - - 1件:  6  💬
616 Diagnostic test: elecsys (roche) abeta42, ttau and ptau - - - - 5件:  5 ,  6 ,  7 , 17, 127 💬
617 Diagnostic test: flutemetamol f18 injection Flutemetamol 1件: D10231 💬 - - 5件:  5 ,  6 ,  7 , 17, 127 💬
618 Diagnostic test: frontal assessment battery (fab) - - - - 1件:  6  💬
619 Diagnostic test: global deterioration scale (gds) - - - - 1件:  6  💬
620 Diagnostic test: lumipulse (fujirebio) abeta42, ttau and ptau - - - - 5件:  5 ,  6 ,  7 , 17, 127 💬
621 Diagnostic test: measurement of serum level of anti-dementia drug - - - - 1件:  6  💬
622 Diagnostic test: memory alteration test (m@t) - - - - 1件:  6  💬
623 Diagnostic test: mini cognitive examination (mce) - - - - 1件:  6  💬
624 Diagnostic test: neuropsychological assessment - - - - 2件:  6 , 127 💬
625 Diagnostic test: positive and negative affect scale (panas) - - - - 1件:  6  💬
626 Diagnostic test: respiratory muscle strength - - - - 1件:  6  💬
627 Diagnostic test: rey-osterrieth complex figure test (rocft) - - - - 1件:  6  💬
628 Diagnostic test: spanish-complutense verbal learning test (tavec) - - - - 1件:  6  💬
629 Diagnostic test: supplementary neuropsychological assessment - parkinson's disease - - - - 2件:  6 , 127 💬
630 Different diets - - - - 1件:  6  💬
631 Dihydroergotoxine mesylate Ergoloid mesylate 1件: D02268 💬 6件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件:  6  💬
632 Dipivefrin Dipivefrin 1件: D02349 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
633 Dipivefrine Dipivefrin 1件: D02349 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
634 Dipraglurant Dipraglurant - - - 1件:  6  💬
635 Ditropan elixir - - - - 1件:  6  💬
636 Dm - - - - 2件:  6 ,  8  💬
637 Dm-1992 - - - - 1件:  6  💬
638 Dmi - - - - 2件:  6 , 17 💬
639 Dnl151 - - - - 1件:  6  💬
640 Dnl201 - - - - 1件:  6  💬
641 Dns-7801 (high dose) - - - - 1件:  6  💬
642 Dns-7801 (low-dose) - - - - 1件:  6  💬
643 Docosahexaenoic acid Doconexent - - - 7件:  6 , 49, 90, 94, 240, 299, 301 💬
644 Docosahexaenoic acid (dha) Doconexent - - - 3件:  6 , 94, 299 💬
645 Domperidone Domperidone 2件: D01745, D07868 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 5件:  6 , 13, 17, 51, 230 💬
646 Domperidone (drug) Domperidone 2件: D01745, D07868 💬 1件: DRD2 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
647 Dompéridone - - - - 1件:  6  💬
648 Donepezil Donepezil 2件: D00670, D07869 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 9件:  5 ,  6 , 13, 46, 78, 124, 127, 156, 206 💬
649 Donepezil hydrochloride Donepezil 2件: D00670, D07869 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 3件:  6 , 124, 156 💬
650 Donepezil sandoz Donepezil 2件: D00670, D07869 💬 1件: ACHE 💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 1件:  6  💬
651 Dopamine Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 3件:  6 ,  7 , 74 💬
652 Dopamine agent Dopamine 2件: D00633, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
653 Dopamine agonists (pramipexole, ropirinole) Dopamine 4件: D00559, D00633, D05575, D07870 💬 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
654 Dopaminergic agonist + apomorphine Apomorphine 2件: D02004, D07460 💬 2件: DRD1, DRD2 💬 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 1件:  6  💬
655 Dopaminergic agonists - - - - 1件:  6  💬
656 Dops Droxidopa 1件: D01277 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 2件:  6 , 17 💬
657 Doxepin Doxepin 2件: D00814, D07875 💬 3件: HRH1, SLC6A2, SLC6A4 💬 5件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
658 Doxepin and zopiclone Doxepin 3件: D00814, D01372, D07875 💬 19件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬 10件: Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 1件:  6  💬
659 Dpa - - - - 4件:  2 ,  6 , 13, 85 💬
660 Dpa-714-pet/mri - - - - 1件:  6  💬
661 Droxidopa Droxidopa 1件: D01277 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件:  5 ,  6 , 17 💬
662 Droxidopa 100 mg [northera] Droxidopa 1件: D01277 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
663 Duloxetine Duloxetine 2件: D01179, D07880 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 13 💬
664 Duloxetine hydrochloride Duloxetine 2件: D01179, D07880 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
665 Duodopa - - - - 1件:  6  💬
666 Duodopa gel intestinale - - - - 1件:  6  💬
667 Duodopa intestinal gel - - - - 1件:  6  💬
668 Duodopa intestinalgel - - - - 1件:  6  💬
669 Duodopa ld/cd 20/5 mg/ml - - - - 1件:  6  💬
670 Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel - - - - 1件:  6  💬
671 Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
672 Duodopa®intestinal gel - - - - 1件:  6  💬
673 Dynacirc cr (isradipine)